✨ Medicines Distribution Consents




1 DECEMBER 2011 NEW ZEALAND GAZETTE, No. 186 5403


Health


Medicines Act 1981

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Product: Rapamune
Active Ingredient: Sirolimus 0.5mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Wyeth Pharmaceutical Company, Guayama, Puerto Rico

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 28th day of November 2011.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8364


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Arrow Olanzapine 2.5
Active Ingredient: Olanzapine 2.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Cobalt Pharmaceuticals Inc., Ontario, Canada

Product: Arrow Olanzapine 5
Active Ingredient: Olanzapine 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Cobalt Pharmaceuticals Inc., Ontario, Canada

Product: Arrow Olanzapine 7.5
Active Ingredient: Olanzapine 7.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Cobalt Pharmaceuticals Inc., Ontario, Canada

Product: Arrow Olanzapine 10
Active Ingredient: Olanzapine 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Cobalt Pharmaceuticals Inc., Ontario, Canada

Product: Arrow Olanzapine 15
Active Ingredient: Olanzapine 15mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Cobalt Pharmaceuticals Inc., Ontario, Canada

Product: Arrow Olanzapine 20
Active Ingredient: Olanzapine 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Cobalt Pharmaceuticals Inc., Ontario, Canada

Product: Arrow Olanzapine ODT
Active Ingredient: Olanzapine 5mg
Dosage Form: Orodispersible tablet



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 186





✨ LLM interpretation of page content

πŸ₯ Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
28 November 2011
Medicines Act, Provisional Consent, Rapamune, Sirolimus, Pfizer
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines Act, Consent, Arrow Olanzapine, Olanzapine, Arrow Pharmaceuticals